OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
92
Views
8
CrossRef citations to date
0
Altmetric
Original Research
Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics
Fuxin YiDepartment of Neurosurgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, People’s Republic of ChinaCorrespondence[email protected]
, Jianzhou DuDepartment of Neurosurgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, People’s Republic of China
, Weimin NiDepartment of Neurosurgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, People’s Republic of China
& Weixian LiuDepartment of Neurosurgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, People’s Republic of China
Pages 1059-1069
|
Published online: 20 Feb 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.